Azitra Inc (AZTR)

Healthcare | Biotechnology
Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$0.0

Net Income

-$3.9B

Operating Margin

N/A

Free Cash Flow

-$11.2B

Debt / Assets

24.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Azitra Inc (AZTR).
Income Statement (Quarterly) 2026-03-31 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 7,492,500 0
Cost of Revenue 0 0 -228,853 0
Gross Profit 0 0 7,721,353 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,373,359,000 1,850,138,000 6,264,310,845 1,913,400
Operating Expenses 3,933,924,000 3,100,238,000 10,984,081,516 2,929,207
Operating Income -3,933,924,000 -3,100,238,000 -10,976,589,016 -2,929,207
Interest Expense -3,411,000 -1,293,000 5,612 3,851
Income Before Tax -3,927,240,000 -3,068,345,000 -8,951,886,641 -1,009,491
Income Tax Expense 0 0 -9,025,588 0
Net Income -3,927,240,000 -3,068,345,000 -2,393,133 -1,009,491
Per Share
EPS -0.25 -0.23 -0.31 -0.17
EPS Diluted 0.00 0.00 0.00 0.00